JOHNSON & JOHNSON — Director's Dealing 2014

Nov 6, 2014

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: NEVRO CORP (NVRO)
CIK: 0001444380
Period of Report: 2014-11-05

Reporting Person: JOHNSON & JOHNSON (10% Owner)
Reporting Person: JOHNSON & JOHNSON DEVELOPMENT CORP ET AL (10% Owner)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Series B Convertible Preferred Stock	$		Common Stock (2790178)		Indirect
Series C Convertible Preferred Stock	$		Common Stock (246827)		Indirect

Footnotes

F1: The securities reported as being indirectly beneficially owned by the designated Reporting Person are directly beneficially owned by Johnson & Johnson Development Corporation, a wholly-owned subsidiary of the designated Reporting Person.

F2: The shares of Preferred Stock are immediately convertible and have no expiration date. Immediately prior to the closing of the Issuer's initial public offering each outstanding share of Preferred Stock will automatically convert into Common Stock, on a 1-to-1 basis, for no additional consideration.